Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. (21st April 2021)

• Record Type: Journal Article
• Authors: Wagner, Michael J.; Pollack, Seth M.; Cranmer, Lee D.; Thompson, Matthew J.; Maxwell, Shannon; Wright, Stephanie; Khaki, Ali R.; Madeleine, Margaret M.; Grivas, Petros; Kuderer, Nicole M.; Lyman, Gary H.; Loggers, Elizabeth T.
• Is Part Of: Cancer investigation. Volume 39:Number 4(2021)
• Page Start: 315
• Page End: 320
• Publication Date: 2021-04-21
• Subjects: Sarcoma -- COVID-19 -- cohort Study; Cancer -- Periodicals; Oncology -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- Periodicals; 616.994
• DOI: 10.1080/07357907.2021.1903914
• Languages: English
• ISSNs: 0735-7907

Abstract

Abstract: Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.